Android app on Google Play

Analysts Defend Questcor (QCOR) On Free-Fall In Shares

July 10, 2012 3:19 PM EDT Send to a Friend
Get Alerts QCOR Hot Sheet
Price: $95.00 --0%

Rating Summary:
    8 Buy, 8 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 12
Trade QCOR Now!
Join SI Premium – FREE
Analysts are coming out to defend Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) with today's major sell-off after a negative research piece. However, at this point, it's to no avail.

Piper Jaffray reiterated their Outperform rating and $60 price target saying they do not believe generics are a risk. Even if filed, it would be a minimum 30 month stay. The firm specifically talked to Watson Pharmaceuticals, Inc. (NYSE: WPI), which said they have no plans to pursue filing for a generic version.

Shares of QCOR are down over 20 percent.

You May Also Be Interested In

Related Categories

Analyst Comments, Trader Talk

Related Entities

Piper Jaffray

Add Your Comment